Our Latest News

Press Release: Andarta Therapeutics to Advance Parkinson’s Disease Research through Agreement with Teva and Grant from The Michael J. Fox Foundation

Andarta Therapeutics has obtained rights to advance Teva’s fatty acid synthase (FASN) inhibitor program and will be supported by the Michael J. Fox Foundation.